- Home
- VACH vs CTEV Comparison
VACH vs CTEV Comparison
Compare VACH & CTEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VACH
- CTEV
- Stock Information
- Founded
- VACH 2023
- CTEV 1980
- Country
- VACH United States
- CTEV United States
- Employees
- VACH N/A
- CTEV N/A
- Industry
- VACH
- CTEV
- Sector
- VACH
- CTEV
- Exchange
- VACH NYSE
- CTEV NYSE
- Market Cap
- VACH 324.2M
- CTEV 371.3M
- IPO Year
- VACH 2024
- CTEV N/A
- Fundamental
- Price
- VACH $10.29
- CTEV $25.03
- Analyst Decision
- VACH
- CTEV Hold
- Analyst Count
- VACH 0
- CTEV 1
- Target Price
- VACH N/A
- CTEV $19.00
- AVG Volume (30 Days)
- VACH 175.9K
- CTEV 59.4K
- Earning Date
- VACH 01-01-0001
- CTEV 05-08-2025
- Dividend Yield
- VACH N/A
- CTEV N/A
- EPS Growth
- VACH N/A
- CTEV N/A
- EPS
- VACH 0.26
- CTEV N/A
- Revenue
- VACH N/A
- CTEV $927,446,000.00
- Revenue This Year
- VACH N/A
- CTEV $2.18
- Revenue Next Year
- VACH N/A
- CTEV $3.04
- P/E Ratio
- VACH $40.12
- CTEV N/A
- Revenue Growth
- VACH N/A
- CTEV N/A
- 52 Week Low
- VACH $9.95
- CTEV $4.80
- 52 Week High
- VACH $11.20
- CTEV $31.00
- Technical
- Relative Strength Index (RSI)
- VACH N/A
- CTEV N/A
- Support Level
- VACH N/A
- CTEV N/A
- Resistance Level
- VACH N/A
- CTEV N/A
- Average True Range (ATR)
- VACH 0.00
- CTEV 0.00
- MACD
- VACH 0.00
- CTEV 0.00
- Stochastic Oscillator
- VACH 0.00
- CTEV 0.00
About VACH VOYAGER ACQUISITION CORP.
Voyager Acquisition Corp is a blank check company.
About CTEV CLARITEV CORPORATION
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.